Clinical Trial Update: Prolonged Progesterone to Prevent Preterm Birth From IVF - ET [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating prolonged progesterone to prevent preterm birth after IVF/embryo transfer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• PROGESTERONE (Progesterone)

Snippet

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Conditions: Preterm Birth | Phase 4 | Status: UNKNOWN